This article was originally published in The Gray Sheet
Firms ink two three-year distribution agreements, one giving USSC non-exclusive, worldwide rights to market General Surgical Innovation's Spacemaker surgical balloon dissectors for use in hernia repair and incontinence procedures. In return, GSI acquires non-exclusive, worldwide rights to market USSC's ProTack mesh fixation device as part of a complete hernia repair kit. In February, GSI's exclusive rights agreement with Ethicon for the Spacemaker was downgraded to nonexclusive, opening the door for USSC
You may also be interested in...
Tyco International's $100 mil. stock-swap acquisition of minimally invasive balloon dissection device maker General Surgical Innovations is expected to close within the next 90 days, GSI estimates.
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.